This ia an extended study to protocol V0344g. The purpose is to allow all patients to receive active vaccine for a minimum of 18 months and to provide extended immunization for those who have received either or both of the gp 120 vaccines as part of the previous protocol.
Showing the most recent 10 out of 1085 publications